Market Cap 84.65B
Revenue (ttm) 40.10B
Net Income (ttm) 3.29B
EPS (ttm) N/A
PE Ratio 9.80
Forward PE 9.08
Profit Margin 8.21%
Debt to Equity Ratio 1.35
Volume 4,420,011
Avg Vol 5,598,576
Day's Range N/A - N/A
Shares Out 2.06B
Stochastic %K 100%
Beta 0.51
Analysts Sell
Price Target $39.68

Latest News on GSK

GSK's Blood-Cancer Treatment Combinations Approved in Japan

May 19, 2025, 2:41 AM EDT - 15 days ago

GSK's Blood-Cancer Treatment Combinations Approved in Japan


GSK to buy efimosfermin for up to $2 billion

May 14, 2025, 2:24 AM EDT - 20 days ago

GSK to buy efimosfermin for up to $2 billion


ITeos, GSK discontinue lung cancer therapy development

May 13, 2025, 8:21 AM EDT - 20 days ago

ITeos, GSK discontinue lung cancer therapy development


New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 26 days ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA NVAX PFE IBB SRPT XBI


5 Reasons GSK Looks Good

May 5, 2025, 11:37 AM EDT - 4 weeks ago

5 Reasons GSK Looks Good


GSK plc (GSK) Q1 2025 Earnings Conference Call Transcript

Apr 30, 2025, 12:32 PM EDT - 4 weeks ago

GSK plc (GSK) Q1 2025 Earnings Conference Call Transcript


GSK Sales, Profit Rise on Boost from Cancer Drugs

Apr 30, 2025, 2:27 AM EDT - 4 weeks ago

GSK Sales, Profit Rise on Boost from Cancer Drugs


Pharma firms maastraz

Apr 29, 2025, 12:06 PM EDT - 4 weeks ago

Pharma firms maastraz

AZN NVO NVS